Key Takeaways
- • Sam Brinkley elevated to partner at Amulet Capital, advancing from principal rank held since 2024, marking continued progression within the healthcare-focused investment firm.
- • Brinkley joined Amulet Capital in 2020 as vice president, demonstrating a six-year tenure trajectory aligned with institutional promotion cadence in alternative asset management.
- • Brinkley has established domain expertise in fertility and reproductive health investments, a specialized sector within healthcare dealmaking where Amulet maintains active investment exposure.
- • The promotion reflects Amulet Capital's strategic focus on healthcare-sector M&A and investment activity, with Brinkley positioned as a lead dealmaker in this vertical.
Summary
Sam Brinkley has been promoted to partner at Amulet Capital, the alternative investment firm focused on healthcare sector opportunities. The promotion caps a six-year tenure at the firm, during which Brinkley progressed through established career ranks: joining in 2020 as vice president, advancing to principal in 2024, and now reaching partnership status.
Throughout his role at Amulet, Brinkley has developed specialized expertise in fertility and reproductive health investments, a niche segment within the broader healthcare market. His promotion reflects his contributions as a leading dealmaker in this therapeutic area, signaling the firm's continued commitment to concentrated healthcare sector exposure and active M&A activity.
The career progression underscores typical partnership development timelines at alternative asset managers, where demonstrated deal execution, sector knowledge, and client relationship management typically inform elevation to partnership. Brinkley's focus on fertility and reproductive health—an increasingly active M&A sector driven by regulatory, demographic, and market dynamics—positions him to lead the firm's deal activity in this specialized vertical going forward.
Throughout his role at Amulet, Brinkley has developed specialized expertise in fertility and reproductive health investments, a niche segment within the broader healthcare market. His promotion reflects his contributions as a leading dealmaker in this therapeutic area, signaling the firm's continued commitment to concentrated healthcare sector exposure and active M&A activity.
The career progression underscores typical partnership development timelines at alternative asset managers, where demonstrated deal execution, sector knowledge, and client relationship management typically inform elevation to partnership. Brinkley's focus on fertility and reproductive health—an increasingly active M&A sector driven by regulatory, demographic, and market dynamics—positions him to lead the firm's deal activity in this specialized vertical going forward.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.